Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists.

Bewley, M.A., Budd, R.C., Ryan, E. et al. (21 more authors) (2018) Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists. American Journal of Respiratory and Critical Care Medicine, 198 (6). ISSN 1073-449X

Abstract

Metadata

Authors/Creators:
  • Bewley, M.A.
  • Budd, R.C.
  • Ryan, E.
  • Cole, J.
  • Collini, P. ORCID logo https://orcid.org/0000-0001-6696-6826
  • Marshall, J.
  • Kolsum, U.
  • Beech, G.
  • Emes, R.D.
  • Tcherniaeva, I.
  • Berbers, G.A.M.
  • Walmsley, S.R.
  • Donaldson, G.
  • Wedzicha, J.A.
  • Kilty, I.
  • Rumsey, W.
  • Sanchez, Y.
  • Brightling, C.E.
  • Donnelly, L.E.
  • Barnes, P.J.
  • Singh, D.
  • Whyte, M.K.B.
  • Dockrell, D.H.
  • COPDMAP
Copyright, Publisher and Additional Information: © 2018 American Thoracic Society. This is an author produced version of a paper subsequently published in American Journal of Respiratory and Critical Care Medicine. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Anti-oxidant; COPD; Macrophage; Nrf2; Phagocytosis
Dates:
  • Accepted: 14 March 2018
  • Published (online): 16 March 2018
  • Published: 15 September 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 17 May 2018 14:08
Last Modified: 03 Dec 2020 11:41
Status: Published
Publisher: American Thoracic Society
Refereed: Yes
Identification Number: https://doi.org/10.1164/rccm.201705-0903OC
Related URLs:

Share / Export

Statistics